hypercortisolism - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 16655

<< First< Prev

Page of 833

Next >Last >>

Did you mean: ypercortisolism (1 items)

Select item 96816101.

Approach to the Patient: Diagnosis of Cushing Syndrome

Mesut Savas, Sonal Mehta, Nidhi Agrawal, Elisabeth F C van Rossum, Richard A Feelders

J Clin Endocrinol Metab. 2022 Nov; 107(11): 3162–3174. Published online 2022 Aug 29. doi: 10.1210/clinem/dgac492

PMCID:: PMC9681610

Article

Select item 103344852.

Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome

James W Findling, Hershel Raff

J Endocr Soc. 2023 Jul 3; 7(8): bvad087. Published online 2023 Jun 23. doi: 10.1210/jendso/bvad087

PMCID:: PMC10334485

Article PDF–556K

Select item 101374943.

Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine Perspective

Kade C. Flowers, Kate E. Shipman

Diagnostics (Basel) 2023 Apr; 13(8): 1415. Published online 2023 Apr 14. doi: 10.3390/diagnostics13081415

PMCID:: PMC10137494

Article PDF–2.3M

Select item 92822704.

The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality

Padiporn Limumpornpetch, Ann W Morgan, Ana Tiganescu, Paul D Baxter, Victoria Nyawira Nyaga, Mar Pujades-Rodriguez, Paul M Stewart

J Clin Endocrinol Metab. 2022 Aug; 107(8): 2377–2388. Published online 2022 Apr 29. doi: 10.1210/clinem/dgac265

PMCID:: PMC9282270

Article

Select item 79477585.

The Hypothalamic-Pituitary-Thyroid Axis in Cushing Syndrome Before and After Curative Surgery

Skand Shekhar, Raven McGlotten, Sunyoung Auh, Kristina I Rother, Lynnette K Nieman

J Clin Endocrinol Metab. 2021 Mar; 106(3): e1316–e1331. Published online 2020 Nov 24. doi: 10.1210/clinem/dgaa858

PMCID:: PMC7947758

Article

Select item 19285446.

Islet-cell Carcinoma (Zollinger—Ellison Syndrome) with Fulminating Adrenocortical Hyperfunction and Hypokalemia

M. C. Geokas, J. Youl Chun, J. J. Dinan, I. T. Beck

Can Med Assoc J. 1965 Jul 24; 93(4): 137–143.

PMCID:: PMC1928544

Summary Page Browse PDF–2.0M

Select item 57651887.

Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome

Shi Chen, Ran Li, Lin Lu, Lian Duan, Xuebin Zhang, Anli Tong, Hui Pan, Huijuan Zhu, Zhaolin Lu

Endocrine. 2018; 59(1): 183–190. Published online 2017 Nov 1. doi: 10.1007/s12020-017-1436-9

PMCID:: PMC5765188

Article PDF–518K

Select item 63419838.

Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome

A. Tirosh, M. B. Lodish, G. Z. Papadakis, C. Lyssikatos, E. Belyavskaya, C. A. Stratakis

Horm Metab Res. Author manuscript; available in PMC 2019 Jan 22.

Published in final edited form as: Horm Metab Res. 2016 Sep; 48(10): 677–681. Published online 2016 Sep 19. doi: 10.1055/s-0042-115644

PMCID:: PMC6341983

Article PDF–410K

Select item 63789529.

Mini-Review of Hair Cortisol Concentration for Evaluation of Cushing syndrome

Aaron Hodes, Jerrold Meyer, Maya B. Lodish, Constantine A. Stratakis, Mihail Zilbermint

Expert Rev Endocrinol Metab. Author manuscript; available in PMC 2019 Sep 20.

Published in final edited form as: Expert Rev Endocrinol Metab. 2018 Sep; 13(5): 225–231. Published online 2018 Sep 20. doi: 10.1080/17446651.2018.1517043

PMCID:: PMC6378952

Article PDF–636K

Select item 344474610.

Massive Neonatal Adrenal Enlargement Due to Cytomegaly, Persistence of the Transient Cortex, and Hyperplasia of the Permanent Cortex: Findings in Cushing Syndrome Associated With Hemihypertrophy

J. Aidan Carney, Josephine Ho, Kazuteru Kitsuda, William F. Young, Jr, Constantine A. Stratakis

Am J Surg Pathol. Author manuscript; available in PMC 2013 Oct 1.

Published in final edited form as: Am J Surg Pathol. 2012 Oct; 36(10): 1452–1463. doi: 10.1097/PAS.0b013e31825d538b

PMCID:: PMC3444746

Article PDF–6.3M

Select item 938770011.

Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited

Leah T Braun, Frederick Vogel, Stephanie Zopp, Thomas Marchant Seiter, German Rubinstein, Christina M Berr, Heike Künzel, Felix Beuschlein, Martin Reincke

J Clin Endocrinol Metab. 2022 Sep; 107(9): e3723–e3730. Published online 2022 Jun 22. doi: 10.1210/clinem/dgac379

PMCID:: PMC9387700

Article

Select item 1018831012.

Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France

Alexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, Christine Do Cao, Aurore Geslot, Delphine Drui, Hélène Lasolle, Oceana Vieira-Pinto, Sylvie Salenave, Maud François, Marie Puerto, Hélène Du Boullay, Anne Mayer, Anne Rod, Claire Laurent, Philippe Chanson, Yves Reznik, Frédéric Castinetti, Olivier Chabre, Eric Baudin, Gérald Raverot, Antoine Tabarin, Jacques Young

J Clin Endocrinol Metab. 2023 Jun; 108(6): 1475–1487. Published online 2022 Dec 6. doi: 10.1210/clinem/dgac691

PMCID:: PMC10188310

Article

Select item 488987213.

Diagnosis and clinical genetics of Cushing syndrome in pediatrics

Constantine A. Stratakis

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 Jun 1.

Published in final edited form as: Endocrinol Metab Clin North Am. 2016 Jun; 45(2): 311–328. doi: 10.1016/j.ecl.2016.01.006

PMCID:: PMC4889872

Article PDF–1.8M

Select item 825833814.

Cushing Syndrome Associated Myopathy: It Is Time for a Change

Martin Reincke

Endocrinol Metab (Seoul) 2021 Jun; 36(3): 564–571. Published online 2021 Jun 18. doi: 10.3803/EnM.2021.1069

PMCID:: PMC8258338

Article PDF–685K

Select item 570501415.

The Limited Ability Of Inferior Petrosal Sinus Sampling With Corticotropin-Releasing Hormone To Distinguish Cushing Disease From Pseudo-Cushing States or Normal Physiology

Jack A. Yanovski, Gordon B. Cutler, Jr, John L. Doppman, Donald L. Miller, George P. Chrousos, Edward H. Oldfield, Lynnette K. Nieman

J Clin Endocrinol Metab. Author manuscript; available in PMC 2017 Nov 28.

Published in final edited form as: J Clin Endocrinol Metab. 1993 Aug; 77(2): 503–509. doi: 10.1210/jcem.77.2.8393887

PMCID:: PMC5705014

Article PDF–780K

Select item 404218216.

Familial Micronodular Adrenocortical Disease, Cushing Syndrome, and Mutations of the Gene Encoding Phosphodiesterase 11A4 (PDE11A)

J. Aidan Carney, Rolf C. Gaillard, Jérôme Bertherat, Constantine A. Stratakis

Am J Surg Pathol. Author manuscript; available in PMC 2014 Jun 3.

Published in final edited form as: Am J Surg Pathol. 2010 Apr; 34(4): 547–555. doi: 10.1097/PAS.0b013e3181d31f49

PMCID:: PMC4042182

Article PDF–1.4M

Select item 748095617.

Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome

Joshua Kannankeril, Ty Carroll, James W Findling, Bradley Javorsky, Ian L Gunsolus, Jonathan Phillips, Hershel Raff

J Endocr Soc. 2020 Oct 1; 4(10): bvaa107. Published online 2020 Jul 24. doi: 10.1210/jendso/bvaa107

PMCID:: PMC7480956

Article PDF–213K

Select item 608099618.

The Investigation of Cushing Syndrome: Essentials in Optimizing Appropriate Diagnosis and Management

Agata Juszczak, Ashley Grossman

Ann Saudi Med. 2012 Sep-Oct; 32(5): 455–461. doi: 10.5144/0256-4947.2012.455

PMCID:: PMC6080996

Article PDF–416K

Select item 869451919.

The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome

Justine Herndon, Ravinder Jeet Kaur, Mark Romportl, Emily Smith, Amy Koenigs, Brenda Partlow, Leonardo Arteaga, Irina Bancos

J Endocr Soc. 2022 Jan 1; 6(1): bvab169. Published online 2021 Dec 2. doi: 10.1210/jendso/bvab169

PMCID:: PMC8694519

Article PDF–531K

Select item 799462020.

Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism

Crystal D. C. Kamilaris, Constantine A. Stratakis, Fady Hannah-Shmouni

Front Endocrinol (Lausanne) 2021; 12: 632543. Published online 2021 Mar 12. doi: 10.3389/fendo.2021.632543

PMCID:: PMC7994620

Article PDF–1.1M

Did you mean: ypercortisolism (1 items)

<< First< Prev

Page of 833

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for hypercortisolism

Figure 1.

Biochemical evaluation of suspected adrenal hypercortisolism. Assessment of hypercortisolism, based on biochemical assays, should include a degree of clinical suspicion to reduce the likelihood of false-positive results. *DST, dexamethasone suppression test; to be used as a unique, first-line screening test in the absence of overt signs and/or symptoms of hypercortisolism. **Repeat every 6 months if clinically suggestive of hypercortisolism. ACTH, adrenocorticotropic hormone; CRH, corticotropin-releasing hormone; DHEAS, dehydroepiandrosterone sulfate; LNSC, late-night salivary cortisol; UFC, urinary-free cortisol.

Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities

J Endocr Soc. 2019 May 1;3(5):1097-1109.
Figure 1

Flowchart of 306 dogs with pituitary‐dependent hypercortisolism (PDH) that underwent transsphenoidal hypophysectomy (Hx) in the period 1993–2013.

The Influence of Pituitary Size on Outcome After Transsphenoidal Hypophysectomy in a Large Cohort of Dogs with Pituitary‐Dependent Hypercortisolism

J Vet Intern Med. 2016 Jul-Aug;30(4):989-995.
Fig. 4

ApEn (feedback-sensitive regularity), expressed as ratio of observed to random series, in patients with pituitary-dependent hypercortisolism, patients with primary-adrenal hypercortisolism, and healthy subjects. Patients with unilateral adenoma are represented by triangles and patients with bilateral nodular hyperplasia by diamonds. The P value reflects the difference in mean ApEn ratio between primary-adrenal hypercortisolism and controls. ApEn ratios were similar in the different forms of hypercortisolism.

Irregular and Frequent Cortisol Secretory Episodes with Preserved Diurnal Rhythmicity in Primary Adrenal Cushing’s Syndrome

J Clin Endocrinol Metab. ;90(3):1570-1577.
Fig. 1.

Mean (sem) levels of biochemical markers of bone turnover, sclerostin, and FGF23 in patients with endogenous hypercortisolism at baseline (black bars) and during biochemical remission (gray bars). *, P < 0.05.

Circulating Sclerostin Levels Are Decreased in Patients with Endogenous Hypercortisolism and Increase after Treatment

J Clin Endocrinol Metab. 2012 Oct;97(10):E1953-E1957.